Market Place
Sourcing Support
Tempus, Predicta Expand Access to Genome Sequencing
15 Apr 2026 //
BUSINESSWIRE
Tempus Announces 31 Abstracts for Presentation at AACR 2026
14 Apr 2026 //
BUSINESSWIRE
Tempus And Blood Cancer United Announce Collaboration
17 Mar 2026 //
BUSSINESSWIRE
Tempus, Merck Partner To Advance AI Precision Medicine
03 Mar 2026 //
BUSINESSWIRE
Tempus Reports Fourth Quarter & Full Year 2025 Results
24 Feb 2026 //
BUSINESSWIRE
Tempus to Report Q4, FY 2025 Results on Feb. 24
10 Feb 2026 //
BUSINESSWIRE
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Tempus Unveils 2025 Q4 And Full-Year Results
11 Jan 2026 //
BUSINESSWIRE
Tempus To Present At J.P. Morgan Healthcare Conference
06 Jan 2026 //
BUSINESSWIRE
Tempus Announces 10 Abstracts at 2025 SABCS
09 Dec 2025 //
BUSINESSWIRE
Tempus to Present at Piper Sandler Healthcare Conference
18 Nov 2025 //
BUSINESSWIRE
Tempus Reports Third Quarter 2025 Results
04 Nov 2025 //
BUSINESS WIRE
Tempus To Release Q3 2025 Financial Results On November 4
21 Oct 2025 //
BUSINESSWIRE
Tempus To Present Six Abstracts At Esmo Congress 2025
15 Oct 2025 //
BUSINESSWIRE
Tempus Partners With Parse Biosciences For Certified Services
08 Oct 2025 //
BUSINESSWIRE
Tempus TIME Network Expands Support for Phase I Clinical Trials
01 May 2025 //
BUSINESSWIRE
Tempus Reveals Advisory Board with Top U.S. Physicians
18 Apr 2025 //
BUSINESSWIRE
Tempus & Stemline Partner To Implement AI-Enabled Care For Cancer
21 Feb 2025 //
GLOBENEWSWIRE
Tempus to Report Q4 & Full Year 2024 Financial Results on Feb 24
11 Feb 2025 //
BUSINESSWIRE
Tempus Collaborates with JW Pharmaceutical for R&D Insights
28 Oct 2024 //
BUSINESSWIRE
Avacta And Tempus Collaborate To Advance AI-Driven Drug Development
21 Oct 2024 //
GLOBENEWSWIRE
Tempus Announces Four Abstracts Accepted For Presentation At ESMO 2024
13 Sep 2024 //
BUSINESSWIRE
BerGenBio Collaborates With Tempus To Accelerate STK11m NSCLC Development
20 Aug 2024 //
PR NEWSWIRE
CMS Awards Tempus ADLT Status For xT CDx Test
02 Jul 2024 //
BUSINESSWIRE
Tempus Introduces New HER2 & FOLR1 Testing For Personalized Care
02 Jun 2024 //
BUSINESSWIRE
Tempus Announces Abstracts Accepted For Presentation at the AACR
05 Apr 2024 //
BUSINESSWIRE
Tempus Announces the GEMINI Non-Small Cell Lung Cancer Study
12 Jul 2023 //
BUSINESSWIRE
Tempus Announces Dr. Ned Sharpless as a Senior Strategic Advisor
10 May 2023 //
BUSINESSWIRE
Tempus clocks FDA approval for 648-gene cancer test
08 May 2023 //
FIERCE BIOTECH
Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight
03 Mar 2023 //
ENDPTS
Tempus Announces New Strategic Collaboration with Pfizer
28 Feb 2023 //
BUSINESSWIRE
Tempus Announces Data-Driven Program to Accelerate Precision Oncology Research
27 Oct 2022 //
BUSINESSWIRE
GSK announces expanded collaboration with Tempus in precision medicine
19 Oct 2022 //
PRESS RELEASE
Tempus Announces Companion Diagnostic Collaboration with Kartos Therapeutics
06 Oct 2022 //
BUSINESSWIRE
Tempus Launches Psychiatric Real-World Data Program for Personalized Medicine
20 May 2022 //
BUSINESSWIRE
Tempus’ EDGE Platform Leverages Data & AI to Identify Therapeutic Options
21 Mar 2022 //
BUSINESSWIRE
Kinnate Biopharma Presents Data from its Real-World Clinico-Genomic Study
07 Mar 2022 //
GLOBENEWSWIRE
Tempus Announces the Acquisition of Highline Sciences
08 Feb 2022 //
BUSINESSWIRE
Tempus & GSK Collborate to Begin Open Enrollment for Study of Niraparib
13 Jan 2022 //
BUSINESSWIRE
Janssen taps Tempus` AI for cancer drug discovery
02 Dec 2021 //
FIERCEBIOTECH
Tempus, AstraZeneca Collaborate to Advance Oncology Therapeutics
19 Nov 2021 //
BUSINESSWIRE
Tempus Introduces Diagnostic Test to Its Growing Collection of Algorithms
26 Oct 2021 //
BIOSPACE
Tempus Announces Companion Diagnostic Collaboration With A2 Biotherapeutics
13 Jan 2021 //
BUSINESSWIRE
